{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:24:31Z","timestamp":1784309071765,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0210099"],"award-info":[{"award-number":["JP22fk0210099"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15974"],"award-info":[{"award-number":["JP21K15974"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007263","name":"Astellas Foundation for Research on Metabolic Disorders","doi-asserted-by":"publisher","award":["20203151"],"award-info":[{"award-number":["20203151"]}],"id":[{"id":"10.13039\/501100007263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2023,10,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although genome duplication, or polyploidization, is believed to drive cancer evolution and affect tumor features, its significance in hepatocellular carcinoma (HCC) is unclear. We aimed to determine the characteristics of polyploid HCCs by evaluating chromosome duplication and to discover surrogate markers to discriminate polyploid HCCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The ploidy in human HCC was assessed by fluorescence in situ hybridization for multiple chromosomes. Clinicopathological and expression features were compared between polyploid and near-diploid HCCs. Markers indicating polyploid HCC were explored by transcriptome analysis of cultured HCC cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Polyploidy was detected in 36% (20\/56) of HCCs and discriminated an aggressive subset of HCC that typically showed high serum alpha-fetoprotein, poor differentiation, and poor prognosis compared to near-diploid HCCs. Molecular subtyping revealed that polyploid HCCs highly expressed alpha-fetoprotein but did not necessarily show progenitor features. Histological examination revealed abundant polyploid giant cancer cells (PGCCs) with a distinct appearance and frequent macrotrabecular-massive architecture in polyploid HCCs. Notably, the abundance of PGCCs and overexpression of ubiquitin-conjugating enzymes 2C indicated polyploidy in HCC and efficiently predicted poor prognosis in combination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Histological diagnosis of polyploidy using surrogate markers discriminates an aggressive subset of HCC, apart from known HCC subgroups, and predict poor prognosis in HCC.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1038\/s41416-023-02408-6","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:02:58Z","timestamp":1694779378000},"page":"1251-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis"],"prefix":"10.1038","volume":"129","author":[{"given":"Takanori","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisara","family":"Horisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-3960","authenticated-orcid":false,"given":"Eiji","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-2178","authenticated-orcid":false,"given":"Tomonori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"2408_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton RJ, DiDomizio A, Vittoria MA, Kot\u00fdnkov\u00e1 K, Ticas CJ, Patel S, et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature. 2021;590:492\u20137.","journal-title":"Nature."},{"key":"2408_CR2","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet. 2018;50:1189\u201395.","journal-title":"Nat Genet"},{"key":"2408_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell. 2018;33:676\u201389.e3.","journal-title":"Cancer Cell"},{"key":"2408_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrg.2017.26","volume":"18","author":"Y Van de Peer","year":"2017","unstructured":"Van de Peer Y, Mizrachi E, Marchal K. The evolutionary significance of polyploidy. Nat Rev Genet. 2017;18:411\u201324.","journal-title":"Nat Rev Genet"},{"key":"2408_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","volume":"21","author":"U Ben-David","year":"2020","unstructured":"Ben-David U, Amon A. Context is everything: aneuploidy in cancer. Nat Rev Genet. 2020;21:44\u201362.","journal-title":"Nat Rev Genet"},{"key":"2408_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrclinonc.2017.198","volume":"15","author":"L Sansregret","year":"2018","unstructured":"Sansregret L, Vanhaesebroeck B, Swanton C. Determinants and clinical implications of chromosomal instability in cancer. Nat Rev Clin Oncol. 2018;15:139\u201350.","journal-title":"Nat Rev Clin Oncol"},{"key":"2408_CR7","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1096\/fj.201700247RR","volume":"32","author":"D Wangsa","year":"2018","unstructured":"Wangsa D, Quintanilla I, Torabi K, Vila-Casades\u00fas M, Ercilla A, Klus G, et al. Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness. FASEB J. 2018;32:3502\u201317.","journal-title":"FASEB J"},{"key":"2408_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, et al. The evolutionary history of 2,658 cancers. Nature. 2020;578:122\u20138.","journal-title":"Nature."},{"key":"2408_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen B, Fong C, Luthra A, Smith SA, DiNatale RG, Nandakumar S, et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell 2022;185:563\u201375.e11.","journal-title":"Cell"},{"key":"2408_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/0008-5472.CAN-21-2065","volume":"82","author":"K Prasad","year":"2022","unstructured":"Prasad K, Bloomfield M, Levi H, Keuper K, Bernhard SV, Baudoin NC, et al. Whole-genome duplication shapes the aneuploidy landscape of human cancers. Cancer Res. 2022;82:1736\u201352.","journal-title":"Cancer Res"},{"key":"2408_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.stem.2019.11.014","volume":"26","author":"T Matsumoto","year":"2020","unstructured":"Matsumoto T, Wakefield L, Tarlow BD, Grompe M. In vivo lineage tracing of polyploid hepatocytes reveals extensive proliferation during liver regeneration. Cell Stem Cell. 2020;26:34\u201347.e3.","journal-title":"Cell Stem Cell"},{"key":"2408_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20916-y","volume":"12","author":"T Matsumoto","year":"2021","unstructured":"Matsumoto T, Wakefield L, Peters A, Peto M, Spellman P, Grompe M. Proliferative polyploid cells give rise to tumors via ploidy reduction. Nat Commun. 2021;12:646.","journal-title":"Nat Commun"},{"key":"2408_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI73957","volume":"125","author":"G Gentric","year":"2015","unstructured":"Gentric G, Maillet V, Paradis V, Couton D, L\u2019Hermitte A, Panasyuk G, et al. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Investig. 2015;125:981\u201392.","journal-title":"J Clin Investig"},{"key":"2408_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/gut.2004.043893","volume":"54","author":"H Toyoda","year":"2005","unstructured":"Toyoda H, Bregerie O, Vallet A, Nalpas B, Pivert G, Brechot C, et al. Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis. Gut. 2005;54:297\u2013302.","journal-title":"Gut."},{"key":"2408_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ajcp\/102.1.80","volume":"102","author":"IO Ng","year":"1994","unstructured":"Ng IO, Lai EC, Ho JC, Cheung LK, Ng MM, So MK. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma. Am J Clin Pathol. 1994;102:80\u20136.","journal-title":"Am J Clin Pathol"},{"key":"2408_CR16","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/0016-5085(93)90150-B","volume":"105","author":"N Nagasue","year":"1993","unstructured":"Nagasue N, Kohno H, Hayashi T, Yamanoi A, Uchida M, Takemoto Y, et al. Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma. Gastroenterology. 1993;105:1449\u201354.","journal-title":"Gastroenterology."},{"key":"2408_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/gutjnl-2018-318021","volume":"69","author":"M Bou-Nader","year":"2020","unstructured":"Bou-Nader M, Caruso S, Donne R, Celton-Morizur S, Calderaro J, Gentric G, et al. Polyploidy spectrum: a new marker in HCC classification. Gut. 2020;69:355\u201364.","journal-title":"Gut."},{"key":"2408_CR18","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.celrep.2017.08.069","volume":"20","author":"J Sigl-Gl\u00f6ckner","year":"2017","unstructured":"Sigl-Gl\u00f6ckner J, Brecht M. Polyploidy and the cellular and areal diversity of rat cortical layer 5 pyramidal neurons. Cell Rep. 2017;20:2575\u201383.","journal-title":"Cell Rep"},{"key":"2408_CR19","doi-asserted-by":"crossref","unstructured":"Darzynkiewicz Z. Critical aspects in analysis of cellular DNA content. Curr Protoc Cytom. 2010;7:7.2.","DOI":"10.1002\/0471142956.cy0702s52"},{"key":"2408_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00441-016-2427-5","volume":"368","author":"S Tanami","year":"2017","unstructured":"Tanami S, Ben-Moshe S, Elkayam A, Mayo A, Bahar Halpern K, Itzkovitz S. Dynamic zonation of liver polyploidy. Cell Tissue Res. 2017;368:405\u201310.","journal-title":"Cell Tissue Res"},{"key":"2408_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2021.03.003","volume":"81","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Olszewska A, Klemba A, Marciniak M, Synowiec A, et al. Polyploidy formation in cancer cells: How a Trojan horse is born. Semin Cancer Biol. 2022;81:24\u201336.","journal-title":"Semin Cancer Biol"},{"key":"2408_CR22","doi-asserted-by":"publisher","first-page":"188408","DOI":"10.1016\/j.bbcan.2020.188408","volume":"1874","author":"S Moein","year":"2020","unstructured":"Moein S, Adibi R, da Silva Meirelles L, Nardi NB, Gheisari Y. Cancer regeneration: polyploid cells are the key drivers of tumor progression. Biochim Biophys Acta Rev Cancer. 2020;1874:188408.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2408_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/onc.2013.96","volume":"33","author":"S Zhang","year":"2014","unstructured":"Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene. 2014;33:116\u201328.","journal-title":"Oncogene."},{"key":"2408_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.7150\/jca.17012","volume":"8","author":"D Zhang","year":"2017","unstructured":"Zhang D, Yang X, Yang Z, Fei F, Li S, Qu J, et al. Daughter cells and erythroid cells budding from pgccs and their clinicopathological significances in colorectal cancer. J Cancer. 2017;8:469\u201378.","journal-title":"J Cancer"},{"key":"2408_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/JIR.S345681","volume":"15","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yang Z, Zhang S, Zhou K, Zhang W, Ling S, et al. Polyploidy spectrum correlates with immunophenotype and shapes hepatocellular carcinoma recurrence following liver transplantation. J Inflamm Res. 2022;15:217\u201333.","journal-title":"J Inflamm Res"},{"key":"2408_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","volume":"71","author":"J Calderaro","year":"2019","unstructured":"Calderaro J, Ziol M, Paradis V, Zucman-Rossi J. Molecular and histological correlations in liver cancer. J Hepatol. 2019;71:616\u201330.","journal-title":"J Hepatol"},{"key":"2408_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6.","journal-title":"Nat Rev Dis Prim"},{"key":"2408_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","volume":"72","author":"S Rebouissou","year":"2020","unstructured":"Rebouissou S, Nault JC. Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol. 2020;72:215\u201329.","journal-title":"J Hepatol"},{"key":"2408_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","volume":"67","author":"J Calderaro","year":"2017","unstructured":"Calderaro J, Couchy G, Imbeaud S, Amaddeo G, Letouz\u00e9 E, Blanc JF, et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol. 2017;67:727\u201338.","journal-title":"J Hepatol"},{"key":"2408_CR30","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jhep.2015.07.025","volume":"63","author":"O Miltiadous","year":"2015","unstructured":"Miltiadous O, Sia D, Hoshida Y, Fiel MI, Harrington AN, Thung SN, et al. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation. J Hepatol. 2015;63:1368\u201377.","journal-title":"J Hepatol"},{"key":"2408_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jhep.2013.08.024","volume":"60","author":"SS Zeng","year":"2014","unstructured":"Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, et al. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. J Hepatol. 2014;60:127\u201334.","journal-title":"J Hepatol"},{"key":"2408_CR32","first-page":"1171","volume":"369","author":"S Masuda","year":"2013","unstructured":"Masuda S, Suzuki K, Izpisua Belmonte JC. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 2013;369:1171. United Statesp","journal-title":"N Engl J Med."},{"key":"2408_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.molcel.2017.10.001","volume":"68","author":"A Sakaue-Sawano","year":"2017","unstructured":"Sakaue-Sawano A, Yo M, Komatsu N, Hiratsuka T, Kogure T, Hoshida T, et al. Genetically encoded tools for optical dissection of the mammalian cell cycle. Mol Cell. 2017;68:626\u201340.e5.","journal-title":"Mol Cell"},{"key":"2408_CR34","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1158\/0008-5472.CAN-08-0742","volume":"68","author":"DY Chiang","year":"2008","unstructured":"Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008;68:6779\u201388.","journal-title":"Cancer Res"},{"key":"2408_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s13277-011-0291-1","volume":"33","author":"Z Hao","year":"2012","unstructured":"Hao Z, Zhang H, Cowell J. Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker. Tumour Biol. 2012;33:723\u201330.","journal-title":"Tumour Biol"},{"key":"2408_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X, Dong Z. Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. Mol Cancer. 2021;20:15.","journal-title":"Mol Cancer"},{"key":"2408_CR37","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1038\/onc.2014.332","volume":"34","author":"T Chen","year":"2015","unstructured":"Chen T, Sun Y, Ji P, Kopetz S, Zhang W. Topoisomerase II\u03b1 in chromosome instability and personalized cancer therapy. Oncogene. 2015;34:4019\u201331.","journal-title":"Oncogene."},{"key":"2408_CR38","doi-asserted-by":"publisher","first-page":"12131","DOI":"10.1073\/pnas.2001760117","volume":"117","author":"CF Nielsen","year":"2020","unstructured":"Nielsen CF, Zhang T, Barisic M, Kalitsis P, Hudson DF. Topoisomerase II\u03b1 is essential for maintenance of mitotic chromosome structure. Proc Natl Acad Sci USA. 2020;117:12131\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2408_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2020.11.015","volume":"81","author":"E Sikora","year":"2022","unstructured":"Sikora E, Czarnecka-Herok J, Bojko A, Sunderland P. Therapy-induced polyploidization and senescence: Coincidence or interconnection? Semin Cancer Biol. 2022;81:83\u201395.","journal-title":"Semin Cancer Biol"},{"key":"2408_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413\u201321.","journal-title":"Nat Biotechnol"},{"key":"2408_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","volume":"45","author":"S Boyault","year":"2007","unstructured":"Boyault S, Rickman DS, de Reyni\u00e8s A, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 2007;45:42\u201352.","journal-title":"Hepatology."},{"key":"2408_CR42","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele CD, Abbasi A, Islam SMA, Bowes AL, Khandekar A, Haase K, et al. Signatures of copy number alterations in human cancer. Nature. 2022;606:984\u201391.","journal-title":"Nature."},{"key":"2408_CR43","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-07-6013","volume":"68","author":"T Yamashita","year":"2008","unstructured":"Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008;68:1451\u201361.","journal-title":"Cancer Res"},{"key":"2408_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2174\/1568009618666180703154233","volume":"19","author":"J Chen","year":"2019","unstructured":"Chen J, Niu N, Zhang J, Qi L, Shen W, Donkena KV, et al. Polyploid giant cancer cells (PGCCs): the evil roots of cancer. Curr Cancer Drug Targets. 2019;19:360\u20137.","journal-title":"Curr Cancer Drug Targets"},{"key":"2408_CR45","doi-asserted-by":"publisher","first-page":"4810734","DOI":"10.1155\/2016\/4810734","volume":"2016","author":"S Zhang","year":"2016","unstructured":"Zhang S, Zhang D, Yang Z, Zhang X. Tumor budding, micropapillary pattern, and polyploidy giant cancer cells in colorectal cancer: current status and future prospects. Stem Cells Int. 2016;2016:4810734.","journal-title":"Stem Cells Int"},{"key":"2408_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cytogfr.2019.11.002","volume":"52","author":"D Bharadwaj","year":"2020","unstructured":"Bharadwaj D, Mandal M. Senescence in polyploid giant cancer cells: a road that leads to chemoresistance. Cytokine Growth Factor Rev. 2020;52:68\u201375.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2408_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2021.10.006","volume":"81","author":"J Liu","year":"2022","unstructured":"Liu J, Erenpreisa J, Sikora E. Polyploid giant cancer cells: an emerging new field of cancer biology. Semin Cancer Biol. 2022;81:1\u20134.","journal-title":"Semin Cancer Biol"},{"key":"2408_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.75","volume":"5","author":"N Niu","year":"2016","unstructured":"Niu N, Zhang J, Zhang N, Mercado-Uribe I, Tao F, Han Z, et al. Linking genomic reorganization to tumor initiation via the giant cell cycle. Oncogenesis. 2016;5:e281.","journal-title":"Oncogenesis."},{"key":"2408_CR49","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/onc.2017.72","volume":"36","author":"N Niu","year":"2017","unstructured":"Niu N, Mercado-Uribe I, Liu J. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells. Oncogene. 2017;36:4887\u2013900.","journal-title":"Oncogene."},{"key":"2408_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20572-8","volume":"12","author":"H Lin","year":"2021","unstructured":"Lin H, Huang YS, Fustin JM, Doi M, Chen H, Lai HH, et al. Hyperpolyploidization of hepatocyte initiates preneoplastic lesion formation in the liver. Nat Commun. 2021;12:645.","journal-title":"Nat Commun"},{"key":"2408_CR51","doi-asserted-by":"crossref","unstructured":"Matsumoto T. Implications of polyploidy and ploidy alterations in hepatocytes in liver injuries and cancers. Int J Mol Sci. 2022;23:9409.","DOI":"10.3390\/ijms23169409"},{"key":"2408_CR52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41575-020-0284-x","volume":"17","author":"R Donne","year":"2020","unstructured":"Donne R, Saroul-A\u00efnama M, Cordier P, Celton-Morizur S, Desdouets C. Polyploidy in liver development, homeostasis and disease. Nat Rev Gastroenterol Hepatol. 2020;17:391\u2013405.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02408-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:05:10Z","timestamp":1697180710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10,12]]}},"alternative-id":["2408"],"URL":"https:\/\/doi.org\/10.1038\/s41416-023-02408-6","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the ethics committee of Kobe University School of Medicine. Opt-out consent was obtained because the study was retrospective.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was waived by competent authorities due to the anonymized nature of patient data and the retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}